Acer Therapeutics Inc. (ACER) Gains As Market Dips: What You Should Know
Acer Therapeutics Inc. (ACER) closed at $2.40 in the latest trading session, marking a +1.27% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.02%. At the same time, the Dow added 0.03%, and the tech-heavy Nasdaq gained 5.44%.
Prior to today's trading, shares of the company had lost 4.44% over the past month. This has lagged the Medical sector's loss of 0.87% and the S&P 500's gain of 4.57% in that time.
Wall Street will be looking for positivity from Acer Therapeutics Inc. as it approaches its next earnings report date. The company is expected to report EPS of -$0.39, down 25.81% from the prior-year quarter.
Any recent changes to analyst estimates for Acer Therapeutics Inc. should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Acer Therapeutics Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Drugs industry is part of the Medical sector. This group has a Zacks Industry Rank of 99, putting it in the top 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Acer Therapeutics Inc. (ACER) : Free Stock Analysis Report
